Fundamentals data is not available for this company.
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 1.47 | (246.57) | (188.91)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 6.45 | (324.08) | (256.80)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-27 | 27.66 | (395.44) | (298.11)¢ | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
Viking Therapeutics soars 120% following positiv... | 18-Sep-2018 | ShareCast |
Currency | US Dollars |
Share Price | $ 31.11 |
Change Today | $ -0.18 |
% Change | -0.58 % |
52 Week High | $78.03 |
52 Week Low | $21.28 |
Volume | 2,832,323 |
Shares Issued | 72.03m |
Market Cap | $2,240.78m |
RiskGrade | 326 |
Strong Buy | 7 |
Buy | 10 |
Neutral | 2 |
Sell | 0 |
Strong Sell | 0 |
Total | 19 |
Time | Volume / Share Price |
16:00 | 261,338 @ $31.11 |
16:00 | 100 @ $31.11 |
15:59 | 128 @ $31.11 |
15:59 | 300 @ $31.11 |
15:59 | 200 @ $31.11 |
You are here: research